Product Highlight - TOUJEO
17 Aug 2022
Right Start at the Right Price1,2
Now made even more affordable at Php 1,100 per pen2
- It is used to treat diabetes mellitus in adults, adolescents and children from the age of 6 years.3
- The only 450-unit insulin glargine in the market with the right balance of efficacy, safety and affordability for patients with diabetes.2,4-7
- Effective in lowering HbA1c for a broad range of patient types4-7
- Proven safe with lesser risk of hypoglycemia vs. U100 and other 2nd gen basal insulins4-7
- Flatter profile and less within-day fluctuations vs. U1008
- Now available for only Php 49 per day2,9
REFERENCES:
(1) American Diabetes Association Diabetes Care 2021, Jan; 44(Supplement1): S111-S124. https://doi.org/10.2337/dc21-S009.
(2) Based on Mercury Drug Retail price as of April 2021
(3) Toujeo Prescribing Info 2016
(4) Based on IQVIA retail data as of Dec 2020
(5) Haluzik M. et.al Presented at 79th ADA 2019, June 7-11, SA, CA, US 146-OR
(6) Escalada FJ, et.al Diabetes Obes Metab, 2018;20:2860-2868
(7) Sullivan SD, et al. Presented at 79th ADA 2019, June 7-11, SA, CA, US 133-LB
(8)Charbonnel et al. Presented at 79th ADA 2019, June 7-11, SA, CA, US 133-LB
(9) Bailey et al. DOM Accepted (9) Based on the average daily dose of 20 units using Insulin Glargine U300
This material is strictly for HCPs only.
sanofi-aventis PHILS. INC.
21st to 23rd Flr.
One World Place Corporate Offices.
32nd St. Bonifacio Global City
Taguig City 1634, Metro Manila.
Website: www.sanofi.ph
MAT-PH-2100537 _Ver 1.0 | DA 03-2021 | DM 03-2021
